Point72 Asset Management
RMD icon

Point72 Asset Management’s ResMed RMD Stock Holding History

Point72 Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-800
Closed -$219K – 4123
2025
Q3 		$219K Hold
800
– – ﹤0.01% 2117
2025
Q2 		$206K Buy
+800
New +$191K ﹤0.01% 1979
2025
Q1 		– Sell
-50,000
Closed -$11.4M – 2462
2024
Q4 		$11.4M Buy
+50,000
New +$12M 0.03% 644

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management's RMD Position: Q3 2023 in Review

Point72 Asset Management sold out of ResMed (RMD) in Q3 2023, closing a stake of 605,243 shares — an estimated $132M sold.

Point72 Asset Management first reported a position in RMD in Q4 2014 and held it in 16 quarters. The position peaked at $132M in Q2 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Point72 Asset Management reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 605,243 ResMed shares in Q3 2023, an estimated $132M.
  • Point72 Asset Management first reported a position in ResMed in Q4 2014 and held it in 16 quarters.
  • Point72 Asset Management's ResMed position peaked at $132M in Q2 2023.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.